Subcutaneous fat necrosis (SFN) of the newborn is a self-limiting condition, yet the associated hypercalcemia may result in life-threatening complications. We report a series of four term infants who developed symptomatic hypercalcemia secondary to SFN. Clinical features included firm subcutaneous nodules and elevated serum calcium levels, with suppressed parathyroid hormone (PTH) levels. Management comprises early recognition of SFN-associated hypercalcemia and prompt treatment. We hereby report the use of a single dose of zoledronic acid as an effective therapy for the resolution of hypercalcemia.
ChesoverAD, HarringtonJ, MahmudFH.Pamidronate as first-line treatment of hypercalcemia in neonatal subcutaneous fat necrosis: A case series. Paediatr Child Health. 2021;26(1):e52–e56.
2.
FrankL, BrandtS, WabitschM.Subcutaneous fat necrosis in newborns: A systematic literature review of case reports and model of pathophysiology. Mol Cell Pediatr. 2022;9(1):18.
3.
Di BariJA, NeadJA, SchurmanSJ.Zoledronic acid for neonatal subcutaneous fat necrosis. Clin Case Rep. 2017;5(5):567–569.
4.
IchimiyaH, ArakawaS, SatoT, . Involvement of brown adipose tissue in subcutaneous fat necrosis of the newborn. Dermatology. 2011;223(3):207–210.
5.
SamediV, YusufK, YeeW, ObaidH, Al AwadE.Neonatal hypercalcemia secondary to subcutaneous fat necrosis successfully treated with pamidronate: A case series and literature review. Am J Perinatol Rep. 2014;4(2):e93–e96.
6.
StokesVJ, NielsenMF, HannanFM, ThakkerRV.Hypercalcemic disorders in children. J Bone Miner Res. 2017;32(11):2157–2170.
7.
BowdenSA, MahanJD.Zoledronic acid in pediatric metabolic bone disorders. Transl Pediatr. 2017;6(4):256–268.
8.
Del Pozzo-MaganaBR, HoN.Subcutaneous fat necrosis of the newborn: A 20-year retrospective study. Pediatric Dermatol. 2016;33(6):e353–e355.
9.
MunnsCF, RajabMH, HongJ, . Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone. 2007;41(3):366–370.
10.
BecerirTİ, AltincikA, ÖzhanB, YükselS.Severe hypercalcaemia and acute renal failure in an infant with subcutaneous fat necrosis. Paediatr Int Child Health. 2021;41(3):221–225.
11.
ChrysaidouK, SargiotisG, KaravaV, . Subcutaneous fat necrosis and hypercalcemia with nephrocalcinosis in infancy: Case report and review of the literature. Children (Basel). 2021;8(5):374.
12.
SiegelLH, Fraile AlonsoC, TuazonCFR, . Subcutaneous fat necrosis of the newborn: A retrospective study of 32 infants and care algorithm. Pediatr Dermatol. 2023;40(3):413–421.
13.
MilitelloMA, ReMP, VitalitiG, FinazzoF, ManzoniP, VitalitiSM. Use of zoledronic acid in a neonate with subcutaneous fat necrosis complicated with severe, refractory hypercalcemia. Am J Perinatol. 2019;36:S134–S138.
